News

The trial will explore whether the use of the citrate anticoagulant extends the extracorporeal circuit life in acute kidney patients undergoing continuous renal replacement therapy (CRRT). The first

The drug is intended to be used in combination with letrozole as a first-line treatment of postmenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-)

Allergan acquired Tobira for an upfront payment of $28.35 per share, in cash, and additional Contingent Value Rights (CVRs) that may be payable based on the successful completion

AndexXa is currently under EMA review for reversal of Factor Xa inhibition in patients experiencing a life-threatening or uncontrolled bleed and for patients requiring urgent or emergency surgery.

In April of this year, the companies announced an upfront payment from Gilead of $400m for the acquisition of Nimbus Apollo, and another potential $800m in development-related payments;

The new offering, IBM Watson for Patient Safety, will run on the Watson Health Cloud. The collaboration will combine Watson's cognitive computing ability with Celgene's deep history and experience

According to the people familiar with the matter, Japan’s Takeda Pharmaceutical is expected to acquire Salix gastroenterology business unit for around $10bn. In April 2015, Valeant acquired Salix

Toprol-XL is an extended-release tablet that belongs to a family of high blood pressure medications dubbed beta-blockers. It is indicated for control of hypertension, angina, and heart failure.

The regulator issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for sarilumab, an investigational interleukin-6 receptor (IL-6R) antibody for the treatment of adult patients